Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

Acquisition adds API security testing to Radware’s comprehensive API security portfolio, extending protection to all stages of the API lifecycleMAHWAH, N.J., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Radware® ...

Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...